Newbridge Financial Services Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$1.18K | – | 1142 |
|
|
2024
Q1 | $1.18K | Hold |
100
| – | – | ﹤0.01% | 1036 |
|
|
2023
Q4 | $1.42K | Sell |
100
-95
| -49% | -$1.35K | ﹤0.01% | 999 |
|
|
2023
Q3 | $2.37K | Buy |
195
+100
| +105% | +$1.22K | ﹤0.01% | 1052 |
|
|
2023
Q2 | $1.19K | Hold |
95
| – | – | ﹤0.01% | 1196 |
|
|
2023
Q1 | $1.05K | Hold |
95
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q4 | $1.16K | Hold |
95
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q3 | $1K | Hold |
95
| – | – | ﹤0.01% | 1293 |
|
|
2022
Q2 | $1K | Hold |
95
| – | – | ﹤0.01% | 1269 |
|
|
2022
Q1 | $1K | Hold |
95
| – | – | ﹤0.01% | 1376 |
|
|
2021
Q4 | $1K | Hold |
95
| – | – | ﹤0.01% | 1325 |
|
|
2021
Q3 | $1K | Hold |
95
| – | – | ﹤0.01% | 1258 |
|
|
2021
Q2 | $1K | Hold |
95
| – | – | ﹤0.01% | 1353 |
|
|
2021
Q1 | $1K | Buy |
+95
| New | +$1K | ﹤0.01% | 1271 |
|